{"id":4348,"date":"2025-10-11T10:40:10","date_gmt":"2025-10-11T07:40:10","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=4348"},"modified":"2025-10-11T10:40:11","modified_gmt":"2025-10-11T07:40:11","slug":"kedrion-biopharma-turkiyedeki-hasta-odakli-ve-surdurulebilir-saglik-vizyonunu-paylasti","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=4348","title":{"rendered":"Kedrion Biopharma, T\u00fcrkiye\u2019deki Hasta Odakl\u0131 ve S\u00fcrd\u00fcr\u00fclebilir Sa\u011fl\u0131k Vizyonunu Payla\u015ft\u0131"},"content":{"rendered":"\n

Kedrion Biopharma, \u201cBilimin \u0130nsanl\u0131kla Bulu\u015ftu\u011fu Yer\u201d Yakla\u015f\u0131m\u0131yla Nadir Hastal\u0131klar\u0131n Tedavisinde T\u00fcrkiye\u2019de Hayatlara Dokunmaya Devam Ediyor<\/strong><\/p>\n\n\n\n

\u201cBilimin \u0130nsanl\u0131kla Bulu\u015ftu\u011fu Yer<\/em>\u201d yakla\u015f\u0131m\u0131yla nadir hastal\u0131klar\u0131n tedavisinde global deneyimini T\u00fcrkiye\u2019ye ta\u015f\u0131yan Kedrion Biopharma, \u0130stanbul\u2019da \u0130talyan B\u00fcy\u00fckel\u00e7ili\u011fi\u2019ne ait Palazzo di Venezia\u2019da yap\u0131lan organizasyonda \u00fclkemizdeki faaliyetlerini ve uzun vadeli sa\u011fl\u0131k vizyonunu payla\u015ft\u0131. Toplant\u0131da, plazma t\u00fcrevi tedavilere g\u00fcvenli eri\u015fim, uluslararas\u0131 kalite standartlar\u0131 ve T\u00fcrkiye\u2019nin stratejik rol\u00fc \u00f6n plana \u00e7\u0131kt\u0131.<\/p>\n\n\n\n

T\u00fcrkiye\u2019de 30 Y\u0131l\u0131 A\u015fk\u0131n S\u00fcredir G\u00fcvenli Tedavi Hizmeti<\/strong><\/strong><\/p>\n\n\n\n

\u0130talya merkezli global biyofarmas\u00f6tik \u015firket Kedrion Biopharma<\/strong>, koag\u00fclasyon ve n\u00f6rolojik bozukluklar ile primer ve sekonder imm\u00fcn yetmezlikler gibi nadir ve ciddi hastal\u0131klar\u0131n tedavisinde plazma t\u00fcrevi \u00fcr\u00fcnler sunuyor. 30 y\u0131l\u0131 a\u015fk\u0131n s\u00fcredir T\u00fcrkiye\u2019de faaliyet g\u00f6steren \u015firket, yerel ekibiyle hastalar\u0131n tedavilere g\u00fcvenli ve kesintisiz eri\u015fimini sa\u011flamak i\u00e7in \u00e7al\u0131\u015f\u0131yor.<\/p>\n\n\n\n

Kedrion Biopharma, QSEAL Sertifikas\u0131 ile G\u00fcven ve Kalite Standartlar\u0131n\u0131 Y\u00fckseltiyor<\/strong><\/strong><\/p>\n\n\n\n

Plazma Protein Tedavileri Birli\u011fi\u2019nin (PPTA) g\u00f6n\u00fcll\u00fc QSEAL Sertifikas\u0131\u2019na sahip olan Kedrion, sekt\u00f6rde bilimsel ve operasyonel m\u00fckemmeliyetin temsilcileri aras\u0131nda bulunuyor. PPTA \u00fcyeli\u011fi; ba\u011f\u0131\u015f\u00e7\u0131 tarama ve plazma toplama s\u00fcre\u00e7lerinde en s\u0131k\u0131 standartlar\u0131n uygulanmas\u0131n\u0131, ileri d\u00fczey viral inaktivasyon teknolojilerinin kullan\u0131lmas\u0131n\u0131 ve kapsaml\u0131 kalite kontrol sistemlerinin devreye al\u0131nmas\u0131n\u0131 \u015fart ko\u015fuyor. Etik de\u011ferler ve \u015feffafl\u0131k anlay\u0131\u015f\u0131n\u0131 da temel alan bu yakla\u015f\u0131m sayesinde Kedrion, hasta g\u00fcvenli\u011fi, bilimsel titizlik ve g\u00fcvenilirlik a\u00e7\u0131s\u0131ndan sekt\u00f6r\u00fcn en y\u00fcksek standartlar\u0131n\u0131 temsil eden \u015firketlerden biri olarak \u00f6ne \u00e7\u0131k\u0131yor.<\/p>\n\n\n\n

Kedrion\u2019un sahip oldu\u011fu sertifika, \u015firketin m\u00fckemmeliyete ba\u011fl\u0131l\u0131\u011f\u0131n\u0131 ve kalite anlay\u0131\u015f\u0131n\u0131 ortaya koyuyor. Bu y\u00f6n\u00fcyle de sertifikasyona sahip olmayan tesislerden ayr\u0131\u015fan Kedrion\u2019un CEO\u2019su Ugo Di Francesco, kalite ve g\u00fcvenlik standartlar\u0131na ili\u015fkin \u015funlar\u0131 s\u00f6yledi:<\/strong><\/p>\n\n\n\n

\u201cBug\u00fcn Kedrion, be\u015f \u00fclkedeki yedi modern \u00fcretim tesisi ve geni\u015f plazma merkezleri a\u011f\u0131yla, plazma t\u00fcrevi tedaviler alan\u0131nda d\u00fcnyan\u0131n \u00f6nde gelen be\u015f \u015firketinden biri konumunda. Bu g\u00fc\u00e7l\u00fc k\u00fcresel yap\u0131, yaln\u0131zca \u00fcretim kapasitesini de\u011fil; kaliteye, g\u00fcvenli\u011fe ve insana duyulan derin sayg\u0131y\u0131 da temsil ediyor. Her bir tesisimiz, uluslararas\u0131 standartlara en s\u0131k\u0131 \u015fekilde uyum sa\u011flayacak \u015fekilde tasarlanm\u0131\u015f s\u00fcre\u00e7lerle y\u00f6netiliyor. B\u00f6ylece her \u00fcr\u00fcn\u00fcn kalitesi, g\u00fcvenli\u011fi ve izlenebilirli\u011fi en \u00fcst d\u00fczeyde garanti alt\u0131na al\u0131n\u0131yor.<\/em><\/p>\n\n\n\n

Misyonumuz a\u00e7\u0131k: bilimi insanl\u0131kla bulu\u015fturmak ve ya\u015famlar\u0131 kaliteyle iyile\u015ftirmek. T\u00fcrkiye ise bu misyonun merkezinde yer al\u0131yor. Uzun y\u0131llara dayanan i\u015f birliklerimizle, nadir hastal\u0131klarla ya\u015fayan hastalara umut olma yolculu\u011fumuzun ayr\u0131lmaz bir par\u00e7as\u0131 haline geldi.<\/em><\/p>\n\n\n\n

Kedrion, Plazma Protein Tedavileri Birli\u011fi\u2019nin (PPTA) \u00fcyesi olman\u0131n yan\u0131 s\u0131ra, g\u00f6n\u00fcll\u00fc ve ba\u011f\u0131ms\u0131z bir kalite akreditasyonu olan QSEAL Sertifikas\u0131\u2019na da sahiptir. Bu sertifika, yaln\u0131zca yasal gereklilikleri kar\u015f\u0131lamakla kalmay\u0131p, sekt\u00f6r\u00fcn en ileri kalite ve g\u00fcvenlik standartlar\u0131n\u0131 temsil eden sistemlerimizin bir teyididir. Ba\u011f\u0131\u015f\u00e7\u0131 taramas\u0131ndan plazma toplama ve \u00fcretim protokollerine kadar her ad\u0131m, end\u00fcstrideki en geli\u015fmi\u015f uygulamalar aras\u0131nda yer almaktad\u0131r. Plazma ba\u011f\u0131\u015f\u0131ndan son \u00fcr\u00fcne kadar t\u00fcm s\u00fcre\u00e7ler titizlikle izlenir, belgelenir ve denetlenir. \u00c7\u00fcnk\u00fc biz biliyoruz ki kalite bir s\u00fcre\u00e7 de\u011fil, bir k\u00fclt\u00fcrd\u00fcr. Att\u0131\u011f\u0131m\u0131z her ad\u0131m, hastalara g\u00fcvenli, etkili ve en y\u00fcksek standartlarda tedaviler sunma sorumlulu\u011fumuzun bir par\u00e7as\u0131d\u0131r.<\/em><\/p>\n\n\n\n

T\u00fcrkiye Vizyonu: Her B\u00f6lgeye G\u00fcvenli ve E\u015fit Eri\u015fim<\/strong><\/p>\n\n\n\n

K\u00fcresel kalite standartlar\u0131 ve g\u00fcvenlik taahh\u00fcd\u00fcyle \u00f6ne \u00e7\u0131kan Kedrion, ayn\u0131 zamanda T\u00fcrkiye\u2019ye y\u00f6nelik uzun vadeli vizyonunu da g\u00fc\u00e7l\u00fc bir \u015fekilde ortaya koyuyor. Kedrion\u2019un T\u00fcrkiye\u2019ye y\u00f6nelik stratejik vizyonu, \u015firketin k\u00fcresel misyonu olan \u201cWhere Science Meets Humanity \u2013 Bilimin \u0130nsanl\u0131kla Bulu\u015ftu\u011fu Yer\u201d<\/em> anlay\u0131\u015f\u0131yla birebir \u00f6rt\u00fc\u015f\u00fcyor.<\/p>\n\n\n\n

Bu vizyonu payla\u015fan <\/strong>Kedrion T\u00fcrkiye Genel M\u00fcd\u00fcr\u00fc Sema \u00d6zel Baydar<\/strong>, \u015funlar\u0131 aktard\u0131:<\/strong><\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

\u201c<\/strong>Kedrion T\u00fcrkiye olarak vizyonumuz yaln\u0131zca hastalar\u0131n bireysel sa\u011fl\u0131k ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131lamakla s\u0131n\u0131rl\u0131 kalm\u0131yor; ayn\u0131 zamanda sa\u011fl\u0131k ekosistemine uzun vadeli de\u011fer katmay\u0131 da hedefliyor. <\/em>Nadir hastal\u0131klar, yaln\u0131zca t\u0131bbi bir m\u00fccadele de\u011fil; ayn\u0131 zamanda sab\u0131r, umut ve dayan\u0131\u015fma hikayeleridir. Her bir hastan\u0131n ya\u015fad\u0131\u011f\u0131 yolculuk, bize bilimin ve insanl\u0131\u011f\u0131n birlikte nas\u0131l iyile\u015ftirici bir g\u00fc\u00e7 olu\u015fturabilece\u011fini hat\u0131rlat\u0131yor.
Kedrion olarak biz, bu yolculukta her hastan\u0131n yan\u0131nda olmay\u0131, onlara yaln\u0131z olmad\u0131klar\u0131n\u0131 hissettirmeyi bir sorumluluk de\u011fil, bir insanl\u0131k g\u00f6revi olarak g\u00f6r\u00fcyoruz.<\/em> Nadir hastal\u0131klar\u0131n erken tan\u0131 ve tedavi yolculu\u011funda, bilimin \u00f6nc\u00fc isimleriyle el ele \u00e7al\u0131\u015f\u0131yoruz. Bu g\u00fc\u00e7l\u00fc i\u015f birlikleri sayesinde yaln\u0131zca tedaviye eri\u015fimi de\u011fil, hastalar\u0131n ya\u015fam kalitesini ve hekimlerin bilgiye ula\u015fma g\u00fcc\u00fcn\u00fc de iyile\u015ftirmeyi hedefliyoruz.<\/em>\u201d<\/p>\n\n\n\n

Kedrion, yenilik\u00e7i tedavilere yapt\u0131\u011f\u0131 yat\u0131r\u0131mlar, hasta odakl\u0131 yakla\u015f\u0131m\u0131 ve s\u00fcrd\u00fcr\u00fclebilirlik vizyonuyla yaln\u0131zca bug\u00fcn\u00fcn sa\u011fl\u0131k ihtiya\u00e7lar\u0131na de\u011fil, gelece\u011fin sa\u011fl\u0131k \u00e7\u00f6z\u00fcmlerine de katk\u0131da bulunmay\u0131 ama\u00e7l\u0131yor. \u015eirket, etik de\u011ferler, g\u00fcvenlik ve kalite standartlar\u0131 konusundaki titizli\u011fiyle T\u00fcrkiye\u2019de sa\u011fl\u0131k hizmetlerinde fark yaratmay\u0131 hasta ve hekimlere g\u00fcvenilir bir yol arkada\u015f\u0131 olmay\u0131 ve her bireyin ya\u015fam kalitesini y\u00fckseltmeyi kararl\u0131l\u0131kla s\u00fcrd\u00fcr\u00fcyor.<\/p>\n\n\n\n

T\u00fcrkiye\u2019ye G\u00fc\u00e7l\u00fc Ba\u011fl\u0131l\u0131k<\/strong><\/p>\n\n\n\n

Kedrion\u2019un T\u00fcrkiye\u2019ye y\u00f6nelik stratejik vizyonu, global misyonuyla da birebir \u00f6rt\u00fc\u015f\u00fcyor.<\/p>\n\n\n\n

Bu stratejik vizyonu de\u011ferlendiren Kedrion CEO\u2019su Ugo Di Francesco, T\u00fcrkiye\u2019ye olan ba\u011fl\u0131l\u0131klar\u0131n\u0131 \u015fu s\u00f6zlerle \u00f6zetledi:<\/strong><\/p>\n\n\n\n

\u201cT\u00fcrkiye, bizim i\u00e7in yaln\u0131zca bir \u00fclke de\u011fil; bilimin, insanl\u0131\u011f\u0131n ve ortak de\u011ferlerin bulu\u015ftu\u011fu bir yerdir. 100 y\u0131l\u0131 a\u015fan plazma t\u00fcrevi tedavi deneyimimizle, neredeyse 30 y\u0131ldan fazlad\u0131r T\u00fcrkiye\u2019de nadir hastal\u0131klarla ya\u015fayan hastalara ve ailelerine destek olmay\u0131 bir sorumluluk de\u011fil, bir g\u00f6n\u00fcl ba\u011f\u0131 olarak g\u00f6r\u00fcyoruz. Bilimin rehberli\u011finde, kalite ve g\u00fcvenlikten \u00f6d\u00fcn vermeden, her hastan\u0131n hayat\u0131na dokunacak \u00e7\u00f6z\u00fcmler \u00fcretmeye devam edece\u011fiz.<\/em><\/p>\n\n\n\n

Bu vesileyle, bug\u00fcn bizlere ev sahipli\u011fi yapan \u0130talyan B\u00fcy\u00fckel\u00e7isi Giorgio Marrapodi\u2019ye ve ekibine i\u00e7ten te\u015fekk\u00fcrlerimi sunmak isterim. T\u00fcrkiye ile \u0130talya aras\u0131ndaki bu g\u00fc\u00e7l\u00fc ba\u011f, bizlere gelece\u011fe dair daha b\u00fcy\u00fck bir umut veriyor.<\/em>\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

Kedrion Biopharma, \u201cBilimin \u0130nsanl\u0131kla Bulu\u015ftu\u011fu Yer\u201d Yakla\u015f\u0131m\u0131yla Nadir Hastal\u0131klar\u0131n Tedavisinde T\u00fcrkiye\u2019de Hayatlara Dokunmaya Devam Ediyor<\/p>\n

\u201cBilimin \u0130nsanl\u0131kla Bulu\u015ftu\u011fu Yer\u201d yakla\u015f\u0131m\u0131yla nadir hastal\u0131klar\u0131n tedavisinde global deneyimini T\u00fcrkiye\u2019ye ta\u015f\u0131yan Kedrion Biopharma, \u0130stanbul\u2019da \u0130talyan B\u00fcy\u00fckel\u00e7ili\u011fi\u2019ne ait Palazzo di Venezia\u2019da yap\u0131lan organizasyonda \u00fclkemizdeki faaliyetlerini ve uzun vadeli sa\u011fl\u0131k vizyonunu payla\u015ft\u0131. Toplant\u0131da, plazma t\u00fcrevi tedavilere g\u00fcvenli eri\u015fim, uluslararas\u0131 kalite standartlar\u0131 ve T\u00fcrkiye\u2019nin stratejik rol\u00fc \u00f6n plana \u00e7\u0131kt\u0131.<\/p>\n","protected":false},"author":1,"featured_media":4349,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,42],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4348"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4348"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4348\/revisions"}],"predecessor-version":[{"id":4351,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4348\/revisions\/4351"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/4349"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}